These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 36195583)

  • 21. Role of renin-angiotensin system in acute kidney injury-chronic kidney disease transition.
    Chou YH; Chu TS; Lin SL
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():121-125. PubMed ID: 30298669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiological Role of Organelle Stress/Crosstalk in AKI-to-CKD Transition.
    Maekawa H; Inagi R
    Semin Nephrol; 2019 Nov; 39(6):581-588. PubMed ID: 31836040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential role of nicotinamide adenine dinucleotide deficiency in acute and chronic kidney disease.
    Faivre A; Katsyuba E; Verissimo T; Lindenmeyer M; Rajaram RD; Naesens M; Heckenmeyer C; Mottis A; Feraille E; Cippà P; Cohen C; Longchamp A; Allagnat F; Rutkowski JM; Legouis D; Auwerx J; de Seigneux S
    Nephrol Dial Transplant; 2021 Jan; 36(1):60-68. PubMed ID: 33099633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tubular Cell Cycle Response upon AKI: Revising Old and New Paradigms to Identify Novel Targets for CKD Prevention.
    De Chiara L; Conte C; Antonelli G; Lazzeri E
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IRF-4 deficiency reduces inflammation and kidney fibrosis after folic acid-induced acute kidney injury.
    Chen M; Wen X; Gao Y; Liu B; Zhong C; Nie J; Liang H
    Int Immunopharmacol; 2021 Nov; 100():108142. PubMed ID: 34555644
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy.
    Hu MC; Shi M; Gillings N; Flores B; Takahashi M; Kuro-O M; Moe OW
    Kidney Int; 2017 May; 91(5):1104-1114. PubMed ID: 28131398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potential targeted therapy and diagnosis based on novel insight into growth factors, receptors, and downstream effectors in acute kidney injury and acute kidney injury-chronic kidney disease progression.
    Gao L; Zhong X; Jin J; Li J; Meng XM
    Signal Transduct Target Ther; 2020 Feb; 5(1):9. PubMed ID: 32296020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FoxO3 activation in hypoxic tubules prevents chronic kidney disease.
    Li L; Kang H; Zhang Q; D'Agati VD; Al-Awqati Q; Lin F
    J Clin Invest; 2019 Mar; 129(6):2374-2389. PubMed ID: 30912765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Role of Mitochondria in Acute Kidney Injury and Chronic Kidney Disease and Its Therapeutic Potential.
    Zhang X; Agborbesong E; Li X
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AKI: an increasingly recognized risk factor for CKD development and progression.
    Kurzhagen JT; Dellepiane S; Cantaluppi V; Rabb H
    J Nephrol; 2020 Dec; 33(6):1171-1187. PubMed ID: 32651850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. From AKI to CKD: Maladaptive Repair and the Underlying Mechanisms.
    Wang Z; Zhang C
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability.
    Wu M; Chen W; Miao M; Jin Q; Zhang S; Bai M; Fan J; Zhang Y; Zhang A; Jia Z; Huang S
    Clin Sci (Lond); 2021 Jul; 135(14):1707-1726. PubMed ID: 34255035
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neat1 promotes acute kidney injury to chronic kidney disease by facilitating tubular epithelial cells apoptosis via sequestering miR-129-5p.
    Ma T; Li H; Liu H; Peng Y; Lin T; Deng Z; Jia N; Chen Z; Wang P
    Mol Ther; 2022 Oct; 30(10):3313-3332. PubMed ID: 35619557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cellular senescence and acute kidney injury.
    Lin X; Jin H; Chai Y; Shou S
    Pediatr Nephrol; 2022 Dec; 37(12):3009-3018. PubMed ID: 35338388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polyploid tubular cells and chronic kidney disease.
    De Chiara L; Romagnani P
    Kidney Int; 2022 Nov; 102(5):959-961. PubMed ID: 36272751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary angiotensinogen predicts progressive chronic kidney disease after an episode of experimental acute kidney injury.
    Cui S; Wu L; Feng X; Su H; Zhou Z; Luo W; Su C; Li Y; Shi M; Yang Z; Cao W
    Clin Sci (Lond); 2018 Oct; 132(19):2121-2133. PubMed ID: 30224346
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Divergent effects of AKI to CKD models on inflammation and fibrosis.
    Black LM; Lever JM; Traylor AM; Chen B; Yang Z; Esman SK; Jiang Y; Cutter GR; Boddu R; George JF; Agarwal A
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F1107-F1118. PubMed ID: 29897282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transition of acute kidney injury to chronic kidney disease: role of metabolic reprogramming.
    Zhu Z; Hu J; Chen Z; Feng J; Yang X; Liang W; Ding G
    Metabolism; 2022 Jun; 131():155194. PubMed ID: 35346693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blockade of STAT3 signaling alleviates the progression of acute kidney injury to chronic kidney disease through antiapoptosis.
    Park JY; Yoo KD; Bae E; Kim KH; Lee JW; Shin SJ; Lee JS; Kim YS; Yang SH
    Am J Physiol Renal Physiol; 2022 May; 322(5):F553-F572. PubMed ID: 35311382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic Modification Drives Acute Kidney Injury-to-Chronic Kidney Disease Progression.
    Li Z; Li N
    Nephron; 2021; 145(6):737-747. PubMed ID: 34419948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.